UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of
Report (Date of earliest event reported): January 30, 2007
|
Chembio
Diagnostics, Inc.
|
(Exact
name of registrant as specified in its charter)
|
Nevada
|
000-30379
|
88-0425691
|
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
3661
Horseblock Road, Medford, NY 11763
(Address
of principal executive offices)
(Zip
Code)
Registrant's
telephone number, including area code (631)
924-1135
|
N/A
|
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[
] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[
] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[
] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[
] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
5.02. Departure
of Directors or Principal Officers; Election of Directors; Appointment of
Principal Officers.
(b) On
January 30, 2007, Gerald A. Eppner, a director of Chembio Diagnostics Inc.
(the
“Company”), notified the Company that he will resign as a director of the
Company, effective immediately. At the time of his resignation, as additional
consideration of his time and efforts as a member of the Board of Directors,
the
Company granted Mr. Eppner $20,000, and caused his outstanding unvested stock
options to become vested immediately. In his resignation letter, Mr. Eppner
stated that he did not resign due to any disagreement with the Company, or
because of any matter relating to the Company's operations, policies or
practices. Mr. Eppner reviewed the contents of this Form 8-K prior to its filing
with the SEC.
Item
9.01. Financial Statements and Exhibits
|
Exhibit
Number
|
Description
of Exhibit
|
|
17.1
|
Gerald
A. Eppner’s Resignation Letter
|
|
17.2
|
Chembio’s
Letter Accepting Mr. Eppner’s
Resignation
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
Date:
January 30, 2007 CHEMBIO
DIAGNOSTICS, INC.
By: /s/
Lawrence A. Siebert
Lawrence
A. Siebert
Chief
Executive Officer